Woman and Man
- | Country :
- Canada
- Netherlands
- France
- ...
- | organs : -
- | Specialty : -
Extract
This is a Phase I, multicenter, open-label, dose-escalation study of DCDS4501A administered as a single agent by IV infusion to patients with relapsed or refractory hematologic malignancies. In Phase Ib, patients will receive DCDS4501A in combination with rituximab.
Inclusion criteria
- Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia